BerandaBNTC • NASDAQ
add
Benitec Biopharma Inc
$11,80
Setelah Jam Perdagangan Normal:(0,00%)0,00
$11,80
Tutup: 8 Agu, 16.01.46 GMT-4 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$11,75
Rentang hari
$11,51 - $12,39
Rentang tahun
$8,06 - $17,15
Kapitalisasi pasar
309,76Â jt USD
Volume Rata-Rata
154,87Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | — | — |
Biaya operasional | 10,19Â jt | 145,85% |
Laba bersih | -9,35Â jt | -118,60% |
Margin laba bersih | — | — |
Penghasilan per saham | — | — |
EBITDA | -10,18Â jt | -147,21% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 103,58Â jt | 632,40% |
Total aset | 105,21Â jt | 601,44% |
Total liabilitas | 7,64Â jt | 118,32% |
Total ekuitas | 97,57 jt | — |
Saham yang beredar | 25,60 jt | — |
Harga terhadap nilai buku | 3,08 | — |
Tingkat pengembalian aset | -27,64% | — |
Tingkat pengembalian modal | -29,17% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -9,35Â jt | -118,60% |
Kas dari operasi | -3,09Â jt | 49,97% |
Kas dari investasi | -6,00Â rb | 96,65% |
Kas dari pembiayaan | 28,41 jt | — |
Perubahan kas bersih | 25,30Â jt | 505,99% |
Arus kas bebas | 60,50Â rb | 101,31% |
Tentang
Benitec Biopharma Limited is an Australian biotechnology company founded in 1997. It is engaged in the development of gene-silencing therapies for the treatment of chronic and life-threatening diseases using DNA-directed RNA interference technology.
The CSIRO has researched RNAi extensively, developing the small hairpin RNA concept employed in ddRNAi. Benitec Biopharma has an exclusive license to this ddRNAi technology in human therapeutic uses and research. Wikipedia
Didirikan
1997
Situs
Karyawan
16
